BIG Research in Focus
This issue focuses on personalised breast cancer treatment and, more particularly, on the potential of the new generation of biomarker-driven clinical trials now at the center of much debate. Many questions need to be tackled, as does our thinking about clinical trial designs.
In this issue we have interviewed several experts about the challenges and rewards of incorporating biomarkers into breast cancer research.